LivaNova snags former J & J exec Huston as CFO | Personnel Moves, May 24, 2017

LivaNova (NSDQ:LIVN) said last week that it picked up former Johnson & Johnson medical device group chief financial officer Thad Huston as its new CFO, effective May 20. Huston will replace former CFO Vivid Sehgal, who coordinated with Huston during the transition. Huston spent more than 25 years with Johnson & Johnson, and held various positions, including prez of its Xian-Janssen Pharmaceuticals division in China, finance VP and CFO & COO for its pharmaceutical R&D and finance VP and CFO for its Ortho-McNeil Pharma division. “I am eager to join the exceptional team at LivaNova. We share a passion for making a difference in patients’ lives, while focusing on growth that will lead us to even greater success as a company,” Huston said in a prepared statement. “I am pleased to welcome Thad Huston to LivaNova and to our Executive Leadership Team as our new CFO. Thad is equipped with a strong healthcare and medical device background, coupled with the financial acumen and acuity to enhance our strategic growth plans. I look forward to working together to drive performance, build our pipeline and expand our portfolio in a sustainable manner,” CEO Damien McDonald said in a press release.  Teleflex lifts Deren to VP, CAO Teleflex (NYSE:TFX) said this month it promoted its VP and corporate controller John Deren to VP and chief accounting officer. Prior to his joining Teleflex, Deren acted as VP and global controller at materials manufactur...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Alcon Brainlab Cardiovascular Systems Inc. Fortimedix LivaNova Nativis Novartis sightlife Stimwave Technologies Teleflex Vuzix Source Type: news